Response-guided neoadjuvant sacituzumab govitecan for localized triple-negative breast cancer: results from the NeoSTAR trial

Laura M. Spring, Sara M. Tolaney, Geoffrey Fell, Veerle Bossuyt, Rachel O. Abelman, Bing Wu, Shyamala Maheswaran, Lorenzo Trippa, Amy Comander, Therese M. Mulvey, Sarah A. McLaughlin, Paula D. Ryan, Louise Ryan, Edward Abraham, Aron S. Rosenstock, Ana C. Garrido-Castro, Filipa Lynce, Beverly Moy, Steven J. Isakoff, Nadine Tung, Elizabeth A. Mittendorf, Leif W. Ellisen, Aditya Bardia